OTCMKTS:PARNF Parnell Pharmaceuticals (PARNF) Stock Price, News & Analysis → Putin and other countries have a plan (From Whats On Finance) (Ad) Free PARNF Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Parnell Pharmaceuticals alerts: Email Address Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. About Parnell Pharmaceuticals Stock (OTCMKTS:PARNF)Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.Read More Ad WealthPressThe system that called 2023’s top 7 stocks is at it again…Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! PARNF Stock News HeadlinesMarch 27, 2024 | bbc.co.ukParental mental health and parent wellbeingFebruary 15, 2024 | msn.comThree things to know in Manatee: veteran's memorial park, school zone camerasApril 23, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.February 10, 2024 | finance.yahoo.comParnell Pharmaceuticals Holdings Ltd (PARNF)January 22, 2024 | finance.yahoo.comParnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory MemorandumJanuary 19, 2024 | yahoo.comThe best Netflix original movies right nowJanuary 3, 2024 | cnbc.comHere are 4 of the best parent student loans for collegeNovember 23, 2023 | uk.sports.yahoo.comThree young children among five people injured in stabbing outside a school in DublinApril 23, 2024 | WealthPress (Ad)The system that called 2023’s top 7 stocks is at it again…Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.November 3, 2023 | bbc.co.ukSchooling tips for parents of autistic childrenNovember 1, 2023 | yahoo.comA Halloween guide for parents: How to handle candy, costumes and trick-or-treating safetyOctober 30, 2023 | foxnews.comSchool shooter's parents can be tried for involuntary manslaughter, court rulesOctober 10, 2023 | bizjournals.comBayer puts stake in ground with opening of cell therapy facility in BerkeleySeptember 26, 2023 | washingtonpost.comTeens are crumbling under extreme pressure. Parents need to change.September 13, 2023 | usatoday.comWhat happens when a narcissist becomes a parent? They force their kids into these roles.August 23, 2023 | usatoday.comWell-meaning parents' mistakes kill thousands of kids each year. What can be done?August 3, 2023 | forbes.comBest Lenders To Refinance Parent PLUS Loans Of August 2023July 28, 2023 | dallasnews.comPlano’s Reata Pharmaceuticals strikes a $7.3 billion deal with biotech giant BiogenJune 29, 2023 | finance.yahoo.comPARNF - Parnell Pharmaceuticals Holdings LtdJanuary 6, 2023 | prnewswire.comParnell Pharmaceuticals Holdings Ltd Announces Extension of Rights OfferingDecember 6, 2022 | finance.yahoo.comParnell Pharmaceuticals Holdings Ltd Announces Commencement of Rights OfferingDecember 1, 2022 | finance.yahoo.comParnell Pharmaceuticals Holdings Ltd Announces Proposed Rights OfferingMay 31, 2022 | yahoo.comInflation cutting into Indiana residents wallets, forcing changes for manySee More Headlines Receive PARNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Parnell Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:PARNF Previous SymbolNASDAQ:PARN CUSIPN/A CIKN/A Webwww.parnell.com Phone(129) 667-4411FaxN/AEmployees78Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$25.80 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares82,950,000Free FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesDr. Alan Richard Bell (Age 68)Executive Chairman Mr. Brad R. McCarthy CPA (Age 48)CEO, CFO, Chief Accounting Officer, Company Secretary & Executive Director Key CompetitorsAbliva AB (publ)OTCMKTS:NEVPFAcusphereOTCMKTS:ACUSAddex TherapeuticsOTCMKTS:ADDXFAeolus PharmaceuticalsOTCMKTS:AOLSAffymaxOTCMKTS:AFFYView All Competitors PARNF Stock Analysis - Frequently Asked Questions How do I buy shares of Parnell Pharmaceuticals? Shares of PARNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PARNF) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersIs Tesla going out of business?DTI Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Parnell Pharmaceuticals Holdings Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
